Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;25(4):875-899.
doi: 10.1016/j.cld.2021.07.001.

Novel Therapies That May Cure Chronic Hepatitis B Virus

Affiliations
Review

Novel Therapies That May Cure Chronic Hepatitis B Virus

Alessandro Loglio et al. Clin Liver Dis. 2021 Nov.

Abstract

The hepatitis B virus (HBV) is a member of the Hepadnaviridae family, which includes small DNA enveloped viruses that infect primates, rodents, and birds and is the causative factor of chronic hepatitis B. A common feature of all these viruses is their great specificity by species and cell type, as well as a peculiar genomic and replication organization similar to that of retroviruses. The HBV virion consists of an external lipid envelope and an internal icosahedral protein capsid containing the viral genome and a DNA polymerase, which also functions as a reverse transcriptase.

Keywords: Hepatitis B virus; Immunomodulators; Inhibitors of viral replication; New anti-HBV therapy; Viral antigen inbibitors; Viral replication Inhibitors; Viral replication cycle; cccDNA.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest A. Loglio: speaker bureau for MYR Pharma. M. Viganò, speaker bureau for Gilead and Abbvie. P. Lampertico: advisor and speaker bureau for BMS, Roche, Gilead Sciences, GSK, MSD, Abbvie, Janssen, Arrowhead, Alnylam, Eiger, MYR Pharma, Antios, Aligos.

Publication types

LinkOut - more resources